Attitude towards CATT-positive individuals without parasitological confirmation in the African Trypanosomiasis (T.b. gambiense) focus of Quicama (Angola)

被引:43
作者
Simarro, PP [1 ]
Ruiz, JA [1 ]
Franco, JR [1 ]
Josenando, T [1 ]
机构
[1] Fundacio CIDOB, Ctr Control Tripanosomiasis, Bata, Equat Guinea
关键词
trypanosomiasis; control programme; CATT; Angola; sleeping sickness;
D O I
10.1046/j.1365-3156.1999.00494.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Serologically positive individuals without parasitological confirmation constitute an important problem for trypanosomiasis control programmes because of epidemiological and therapeutical consequences. In July 1997, in the focus of Quicama (Angola), 4753 individuals were screened using CATT/T.b.gambiense on whole blood. In CATT-positive but parasite-negative individuals, CATT titration on serum was performed. Sixteen individuals showing an end-titre lower than 1/4 were considered noninfected according to the results of a previous study of serological status of parasitologically confirmed cases; 86 individuals with end titres greater than or equal to 1/4 were considered suspected of trypanosomiasis and were followed-up from July 1997 to July 1998 with controls every three months. After one year, 32 individuals whose antibody titres dropped < 1/4 were considered noninfected, 22 were confirmed by demonstration of parasites, 17 were further followed-up because antibody titres remained greater than or equal to 1/8 but parasites could not be found. Fifteen individuals did not show up for testing. Following the usual criterion, only parasitologically confirmed cases were treated. However, if it had been decided to treat parasite-negative individuals with a CATT end-titre > 1/8, 22 initially unconfirmed but infected individuals would have been treated earlier, whereas 5 noninfected individuals would have been treated unnecessarily. CATT titration on diluted serum or plasma is useful for making therapeutical decisions.
引用
收藏
页码:858 / 861
页数:4
相关论文
共 7 条
[1]  
BAILLY C, 1995, B LIAISION DOCUMENTA, V28, P182
[2]  
JAMONNEAU V, 1998, INT C SLEEP SICKN RE
[3]  
JANNIN J, 1992, SEM MOD APPL OPT PRI, P61
[4]  
PAQUET C, 1995, B SOC PATHOL EXOT, V88, P38
[5]  
SIMARRO PP, 1991, B WORLD HEALTH ORGAN, V69, P451
[6]  
VANNIEWENHOVE S, 1983, P S DIAGN AFR SLEEP, P71
[7]  
*WHO, 1998, WHO TECHN REP, V881, P46